Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND FOXO3, FKHRL1, 2309, ENSG00000118689, MGC31925, MGC12739, FOXO2, FOXO3A, O43524, AF6q21, FKHRL1P2, DKFZp781A0677 AND Treatment
55 results:

  • 1. 5-methoxytryptophan induced apoptosis and PI3K/Akt/foxo3a phosphorylation in colorectal cancer.
    Zhao TL; Qi Y; Wang YF; Wang Y; Liang H; Pu YB
    World J Gastroenterol; 2023 Dec; 29(47):6148-6160. PubMed ID: 38186686
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Pro-carcinogenic actions of miR-155/foxo3a in colorectal cancer development.
    Wang D; Geng W; Han L; Song R; Qu Q; Chen X; Luo X
    Cell Mol Biol (Noisy-le-grand); 2023 Oct; 69(10):160-165. PubMed ID: 37953568
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. 3-Bromopyruvate overcomes cetuximab resistance in human colorectal cancer cells by inducing autophagy-dependent ferroptosis.
    Mu M; Zhang Q; Zhao C; Li X; Chen Z; Sun X; Yu J
    Cancer Gene Ther; 2023 Oct; 30(10):1414-1425. PubMed ID: 37558749
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Prognostic Assessment of Oxidative Stress-Related Genes in colorectal cancer and New Insights into Tumor Immunity.
    Chen Z; Mei K; Xiao Y; Xiong Y; Long W; Wang Q; Zhong J; Di D; Ge Y; Luo Y; Li Z; Huang Y; Gu R; Wang B
    Oxid Med Cell Longev; 2022; 2022():2518340. PubMed ID: 36299603
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Downregulation of TEX11 promotes S-Phase progression and proliferation in colorectal cancer cells through the foxo3a/COP1/c-Jun/p21 axis.
    Zhang X; Hu F; Zhu B; Jiao X; Li Y; Wu S; Ren G; Li J; Xie Q; Pan Y; Li H; Zhao L
    Oncogene; 2022 Nov; 41(47):5133-5145. PubMed ID: 36258021
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. ANGPTL1, foxo3a-Sox2, and colorectal cancer metastasis.
    Jiang K; Chen H; Ding K
    Clin Sci (Lond); 2022 Sep; 136(18):1367-1370. PubMed ID: 36156125
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Microbial metabolite restricts 5-fluorouracil-resistant colonic tumor progression by sensitizing drug transporters via regulation of foxo3-FOXM1 axis.
    Ghosh S; Singh R; Vanwinkle ZM; Guo H; Vemula PK; Goel A; Haribabu B; Jala VR
    Theranostics; 2022; 12(12):5574-5595. PubMed ID: 35910798
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Oleanolic acid induces HCT116 colon cancer cell death through the p38/foxo3a/Sirt6 pathway.
    Potočnjak I; Šimić L; Vukelić I; Batičić L; Domitrović R
    Chem Biol Interact; 2022 Aug; 363():110010. PubMed ID: 35690101
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. PIK3CA mutations-mediated downregulation of circLHFPL2 inhibits colorectal cancer progression via upregulating PTEN.
    Chong X; Chen J; Zheng N; Zhou Z; Hai Y; Chen S; Zhang Y; Yu Q; Yu S; Chen Z; Bao W; Quan M; Chen ZS; Zhan Y; Gao Y
    Mol Cancer; 2022 May; 21(1):118. PubMed ID: 35619132
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Avenanthramide C induces cellular senescence in colorectal cancer cells via suppressing β-catenin-mediated the transcription of miR-183/96/182 cluster.
    Fu R; Dou Z; Li N; Zhang J; Li Z; Yang P
    Biochem Pharmacol; 2022 May; 199():115021. PubMed ID: 35358479
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. 5-aminosalicylic acid inhibits the expression of oncomiRs and pro-inflammatory microRNAs: an in vitro study.
    Adamowicz M; Milkiewicz P; Kempinska-Podhorodecka A
    J Physiol Pharmacol; 2021 Aug; 72(4):. PubMed ID: 34987126
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. The role of SIRT5 and p53 proteins in the sensitivity of colon cancer cells to chemotherapeutic agent 5-Fluorouracil.
    Ekremoglu O; Koc A
    Mol Biol Rep; 2021 Jul; 48(7):5485-5495. PubMed ID: 34279763
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Acetylshikonin Induces Apoptosis in Human colorectal cancer HCT-15 and LoVo Cells via Nuclear Translocation of foxo3 and ROS Level Elevation.
    Lim HM; Lee J; Nam MJ; Park SH
    Oxid Med Cell Longev; 2021; 2021():6647107. PubMed ID: 33953834
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. A Spatial and Functional Interaction of a Heterotetramer Survivin-DNA-PKcs Complex in DNA Damage Response.
    Güllülü Ö; Hehlgans S; Mayer BE; Gößner I; Petraki C; Hoffmann M; Dombrowsky MJ; Kunzmann P; Hamacher K; Strebhardt K; Fokas E; Rödel C; Münch C; Rödel F
    Cancer Res; 2021 May; 81(9):2304-2317. PubMed ID: 33408118
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Butyrate enhances the efficacy of radiotherapy via foxo3A in colorectal cancer patient‑derived organoids.
    Park M; Kwon J; Shin HJ; Moon SM; Kim SB; Shin US; Han YH; Kim Y
    Int J Oncol; 2020 Dec; 57(6):1307-1318. PubMed ID: 33173975
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Copanlisib promotes growth inhibition and apoptosis by modulating the AKT/foxo3a/PUMA axis in colorectal cancer.
    Yan J; Yang S; Tian H; Zhang Y; Zhao H
    Cell Death Dis; 2020 Nov; 11(11):943. PubMed ID: 33139695
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. EpCAM Signaling Promotes Tumor Progression and Protein Stability of PD-L1 through the EGFR Pathway.
    Chen HN; Liang KH; Lai JK; Lan CH; Liao MY; Hung SH; Chuang YT; Chen KC; Tsuei WW; Wu HC
    Cancer Res; 2020 Nov; 80(22):5035-5050. PubMed ID: 32978170
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Antitumor activity of luteolin in human colon cancer SW620 cells is mediated by the ERK/foxo3a signaling pathway.
    Potočnjak I; Šimić L; Gobin I; Vukelić I; Domitrović R
    Toxicol In Vitro; 2020 Aug; 66():104852. PubMed ID: 32268164
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. foxo3 reverses 5-fluorouracil resistance in human colorectal cancer cells by inhibiting the Nrf2/TR1 signaling pathway.
    Liu C; Zhao Y; Wang J; Yang Y; Zhang Y; Qu X; Peng S; Yao Z; Zhao S; He B; Mi Q; Zhu Y; Liu X; Zou J; Zhang X; Du Q
    Cancer Lett; 2020 Feb; 470():29-42. PubMed ID: 31811910
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Regulation of ATP-binding cassette subfamily B member 1 by Snail contributes to chemoresistance in colorectal cancer.
    Wang H; Li JM; Wei W; Yang R; Chen D; Ma XD; Jiang GM; Wang BL
    Cancer Sci; 2020 Jan; 111(1):84-97. PubMed ID: 31774615
    [TBL] [Abstract] [Full Text] [Related]  


    of 3.